Cargando…

1394. Clinicopathologic Features of Infectious and Noninfectious Tissue Granulomas in Transplant Patients

BACKGROUND: There is a paucity of literature about the implications of granulomatous disease in hematopoietic stem cell transplant (HSCT) and solid-organ transplant (SOT) patients. Given the broad range of infectious and noninfectious etiologies as well as the heightened risk for severe infection, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zachary Nussbaum, Eliezer, Abi Raad, Rita, Malinis, Maricar, Azar, Marwan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808761/
http://dx.doi.org/10.1093/ofid/ofz360.1258
_version_ 1783461814450782208
author Zachary Nussbaum, Eliezer
Abi Raad, Rita
Malinis, Maricar
Azar, Marwan M
author_facet Zachary Nussbaum, Eliezer
Abi Raad, Rita
Malinis, Maricar
Azar, Marwan M
author_sort Zachary Nussbaum, Eliezer
collection PubMed
description BACKGROUND: There is a paucity of literature about the implications of granulomatous disease in hematopoietic stem cell transplant (HSCT) and solid-organ transplant (SOT) patients. Given the broad range of infectious and noninfectious etiologies as well as the heightened risk for severe infection, it is important to characterize the clinicopathologic features of granulomas in this population and to develop a framework to guide further evaluation. METHODS: We performed chart reviews of 1,280 transplant recipients (791 SOT and 489 HSCT) at Yale-New Haven Hospital from 2009 to 2019 to identify patients with granulomas in pathologic specimens obtained peri-transplantation. Data on histopathology, microbiology, indication for biopsy, patient characteristics, and clinical presentation were recorded. Morbidity and mortality were noted at 1, 3, and 12 months after granuloma diagnosis. RESULTS: We identified 28 patients with granulomas (9 SOT, 19 HSCT); an incidence of 2.2%. None had explicit risk factors for MTB. Most granulomas (93%) were non-necrotizing. Common sources were lung (n = 9) and lymph node (n = 5). Most were found post-transplant (n = 19) and biopsies were prompted mostly by symptoms (n = 13) or incidental imaging findings (n = 9). Most granulomas were not associated with an infectious process (n = 20). Among infectious granulomas, bacterial soft-tissue infection (n = 2), bartonellosis (n = 2), and fungal infection (1 Cryptococcus and 1 Blastomyces) were most common. MTB PCR was negative in 4 specimens. Among granulomas discovered in SOT patients, 44% were infectious compared with 21% in HSCT recipients. Most infectious granulomas were found in symptomatic patients (75%). One granuloma-related adverse outcome occurred in a case of cryptogenic organizing pneumonia discovered pre-HSCT that worsened with tapering of immunosuppression post-HSCT. CONCLUSION: Granulomas were uncommon in a large transplant population. Most were deemed noninfectious and their presence alone was not associated with adverse outcomes post-transplant or with increased immunosuppression. Granulomas were more likely to be infectious in SOT recipients and those with symptoms. Symptoms should guide the extent of microbiologic evaluation and reflexive MTB PCR testing is not warranted if risk factors are absent. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6808761
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68087612019-10-28 1394. Clinicopathologic Features of Infectious and Noninfectious Tissue Granulomas in Transplant Patients Zachary Nussbaum, Eliezer Abi Raad, Rita Malinis, Maricar Azar, Marwan M Open Forum Infect Dis Abstracts BACKGROUND: There is a paucity of literature about the implications of granulomatous disease in hematopoietic stem cell transplant (HSCT) and solid-organ transplant (SOT) patients. Given the broad range of infectious and noninfectious etiologies as well as the heightened risk for severe infection, it is important to characterize the clinicopathologic features of granulomas in this population and to develop a framework to guide further evaluation. METHODS: We performed chart reviews of 1,280 transplant recipients (791 SOT and 489 HSCT) at Yale-New Haven Hospital from 2009 to 2019 to identify patients with granulomas in pathologic specimens obtained peri-transplantation. Data on histopathology, microbiology, indication for biopsy, patient characteristics, and clinical presentation were recorded. Morbidity and mortality were noted at 1, 3, and 12 months after granuloma diagnosis. RESULTS: We identified 28 patients with granulomas (9 SOT, 19 HSCT); an incidence of 2.2%. None had explicit risk factors for MTB. Most granulomas (93%) were non-necrotizing. Common sources were lung (n = 9) and lymph node (n = 5). Most were found post-transplant (n = 19) and biopsies were prompted mostly by symptoms (n = 13) or incidental imaging findings (n = 9). Most granulomas were not associated with an infectious process (n = 20). Among infectious granulomas, bacterial soft-tissue infection (n = 2), bartonellosis (n = 2), and fungal infection (1 Cryptococcus and 1 Blastomyces) were most common. MTB PCR was negative in 4 specimens. Among granulomas discovered in SOT patients, 44% were infectious compared with 21% in HSCT recipients. Most infectious granulomas were found in symptomatic patients (75%). One granuloma-related adverse outcome occurred in a case of cryptogenic organizing pneumonia discovered pre-HSCT that worsened with tapering of immunosuppression post-HSCT. CONCLUSION: Granulomas were uncommon in a large transplant population. Most were deemed noninfectious and their presence alone was not associated with adverse outcomes post-transplant or with increased immunosuppression. Granulomas were more likely to be infectious in SOT recipients and those with symptoms. Symptoms should guide the extent of microbiologic evaluation and reflexive MTB PCR testing is not warranted if risk factors are absent. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6808761/ http://dx.doi.org/10.1093/ofid/ofz360.1258 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Zachary Nussbaum, Eliezer
Abi Raad, Rita
Malinis, Maricar
Azar, Marwan M
1394. Clinicopathologic Features of Infectious and Noninfectious Tissue Granulomas in Transplant Patients
title 1394. Clinicopathologic Features of Infectious and Noninfectious Tissue Granulomas in Transplant Patients
title_full 1394. Clinicopathologic Features of Infectious and Noninfectious Tissue Granulomas in Transplant Patients
title_fullStr 1394. Clinicopathologic Features of Infectious and Noninfectious Tissue Granulomas in Transplant Patients
title_full_unstemmed 1394. Clinicopathologic Features of Infectious and Noninfectious Tissue Granulomas in Transplant Patients
title_short 1394. Clinicopathologic Features of Infectious and Noninfectious Tissue Granulomas in Transplant Patients
title_sort 1394. clinicopathologic features of infectious and noninfectious tissue granulomas in transplant patients
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808761/
http://dx.doi.org/10.1093/ofid/ofz360.1258
work_keys_str_mv AT zacharynussbaumeliezer 1394clinicopathologicfeaturesofinfectiousandnoninfectioustissuegranulomasintransplantpatients
AT abiraadrita 1394clinicopathologicfeaturesofinfectiousandnoninfectioustissuegranulomasintransplantpatients
AT malinismaricar 1394clinicopathologicfeaturesofinfectiousandnoninfectioustissuegranulomasintransplantpatients
AT azarmarwanm 1394clinicopathologicfeaturesofinfectiousandnoninfectioustissuegranulomasintransplantpatients